NGLFINE NGL Fine-Chem Q4 FY26 results (Jan–Mar 2026) and concall
NGL Fine Chem reported a strong Q4 and full year FY26, demonstrating significant revenue and profit growth driven by broad-based demand and an expanded API portfolio. While facing external cost pressures and a slight delay in Phase II commissioning, the company is optimistic about continued volume momentum and margin improvement, supported by recent price pass-throughs and ongoing capacity expansion.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 56.8%, net profit up 1200.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 93 | 89 | 95 | 104 | 120 +29% | 128 +44% | 149 +57% |
| EBITDA | 12 | 5 | 6 | 11 | 17 +42% | 22 +340% | 21 +250% |
| Net profit | 10 | 1 | 1 | 9 | 10 +0% | 16 +1500% | 13 +1200% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
